Donze, C.; Min, V.; Ninove, L.; de Lamballerie, X.; Revon Rivière, G.; Verschuur, A.; Saultier, P.; André, N.
BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up. Vaccines 2023, 11, 989.
https://doi.org/10.3390/vaccines11050989
AMA Style
Donze C, Min V, Ninove L, de Lamballerie X, Revon Rivière G, Verschuur A, Saultier P, André N.
BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up. Vaccines. 2023; 11(5):989.
https://doi.org/10.3390/vaccines11050989
Chicago/Turabian Style
Donze, Caroline, Victoria Min, Laetitia Ninove, Xavier de Lamballerie, Gabriel Revon Rivière, Arnauld Verschuur, Paul Saultier, and Nicolas André.
2023. "BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up" Vaccines 11, no. 5: 989.
https://doi.org/10.3390/vaccines11050989
APA Style
Donze, C., Min, V., Ninove, L., de Lamballerie, X., Revon Rivière, G., Verschuur, A., Saultier, P., & André, N.
(2023). BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up. Vaccines, 11(5), 989.
https://doi.org/10.3390/vaccines11050989